Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sarcoma 3Neoplasms 3Brain Neoplasms 3Thyroid Carcinoma, Anaplastic 2Sarcoma, Synovial 2Prostatic Neoplasms 2Neurofibrosarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Gliosarcoma 2Glioblastoma 2Dermatofibrosarcoma 2Carcinoma, Renal Cell 2Breast Neoplasms 2Zollinger-Ellison Syndrome 1Wilms Tumor 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Thyroid Neoplasms 1Somatostatinoma 1Solid Neoplasm 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Recurrent Uterine Corpus Sarcoma 1Recurrent Lymphoepithelioma of the Nasopharynx 1Pheochromocytoma 1Perivascular Epithelioid Cell Neoplasms 1Paraganglioma, Extra-Adrenal 1Paraganglioma 1Ovarian Neoplasms 1

Interventions

Specimen Handling 6cabozantinib 4Magnetic Resonance Spectroscopy 4Trastuzumab 3Gemcitabine 3Biopsy 3eribulin 2atezolizumab 2Nivolumab 2Ipilimumab 2CTLA-4 Antigen 2tipifarnib 1pazopanib 1ixabepilone 1erdafitinib 1entinostat 1enfortumab vedotin 1avelumab 1aflibercept 1Sunitinib 1Sorafenib 1Platinum 1Lenalidomide 1Interleukin-7 1Interleukin-12 Subunit p35 1Interleukin-12 1Immunohistochemistry 1Immunoglobulin G 1Fluorouracil 1Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Urethral Neoplasms × pazopanib × Clear all
NCT00471536 2014-05-30

Pazopanib in Treating Patients With Metastatic Urothelial Cancer

National Cancer Institute (NCI)

Phase 2 Completed
19 enrolled 8 charts
Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡